The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base

Cancer

Volumn 122, Issue 2, 2016, Pages 213-221

  Asare, Elliot A ^a,b   Compton, Carolyn C ^c   Hanna, Nader N ^d   Kosinski, Lauren A ^b   Washington, Mary Kay ^e   Kakar, Sanjay ^f   Weiser, Martin R ^g   Overman, Michael J ^h  

^a ACS   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c ARIZONA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^h UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

appendix; chemotherapy; mucinous; nonmucinous; survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; APPENDECTOMY; APPENDIX CARCINOMA; APPENDIX TUMOR; ARTICLE; AUTOPSY; CANCER GRADING; CANCER MORTALITY; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; COLON RESECTION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MUCINOUS CYSTIC NEOPLASM; OVERALL SURVIVAL; PRIORITY JOURNAL; PROCTOCOLECTOMY; RETROSPECTIVE STUDY; SIGNET RING CARCINOMA; UNDIFFERENTIATED CARCINOMA; ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADJUVANT CHEMOTHERAPY; AGED; APPENDICEAL NEOPLASMS; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; ODDS RATIO; PATHOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; REGISTER; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR INVASION;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; APPENDECTOMY; APPENDICEAL NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84954077482     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29744     Document Type: Article

References (22)

1. McCusker ME, Cote TR, Clegg LX, Sobin LH,. Primary malignant neoplasms of the appendix: a population-based study from the Surveillance, Epidemiology and End Results program, 1973-1998. Cancer. 2002; 94: 3307-3312.
2. Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA,. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol. 2008; 34: 196-201.
3. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2011.
4. Connor SJ, Hanna GB, Frizelle FA,. Appendiceal tumors: retrospective clinicopathologic analysis of appendiceal tumors from 7,970 appendectomies. Dis Colon Rectum. 1998; 41: 75-80.
5. Benedix F, Reimer A, Gastinger I, Mroczkowski P, Lippert H, Kube R,. Primary appendiceal carcinoma-epidemiology, surgery and survival: results of a German multi-center study. Eur J Surg Oncol. 2010; 36: 763-771.
6. Cortina R, McCormick J, Kolm P, Perry RR,. Management and prognosis of adenocarcinoma of the appendix. Dis Colon Rectum. 1995; 38: 848-852.
7. Ito H, Osteen RT, Bleday R, Zinner MJ, Ashley SW, Whang EE,. Appendiceal adenocarcinoma: long-term outcomes after surgical therapy. Dis Colon Rectum. 2004; 47: 474-480.
8. Overman MJ, Fournier K, Hu CY, et al., Improving the AJCC/TNM staging for adenocarcinomas of the appendix: the prognostic impact of histological grade. Ann Surg. 2013; 257: 1072-1078.
9. Davison JM, Choudry HA, Pingpank JF, et al., Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade. Mod Pathol. 2014; 27: 1521-1539.
10. Turaga KK, Pappas SG, Gamblin T,. Importance of histologic subtype in the staging of appendiceal tumors. Ann Surg Oncol. 2012; 19: 1379-1385.
11. Liu X, Mody K, de Abreu FB, et al., Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations. Clin Chem. 2014; 60: 1004-1011.
12. Alakus H, Babicky ML, Ghosh P, et al., Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin. Genome Med. 2014; 6: 43.
13. Taggart MW, Galbincea J, Mansfield PF, et al., High-level microsatellite instability in appendiceal carcinomas. Am J Surg Pathol. 2013; 37: 1192-1200.
14. Misdraji J, Yantiss RK, Graeme-Cook FM, Balis UJ, Young RH,. Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol. 2003; 27: 1089-1103.
15. Chua TC, Moran BJ, Sugarbaker PH, et al., Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012; 30: 2449-2456.
16. Pietrantonio F, Maggi C, Fanetti G, et al., FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma. Oncologist. 2014; 19: 845-850.
17. Tejani MA, Ter Veer A, Milne D, et al., Systemic therapy for advanced appendiceal adenocarcinoma: an analysis from the NCCN Oncology Outcomes Database for colorectal cancer. J Natl Compr Canc Netw. 2014; 12: 1123-1130.
18. Shapiro JF, Chase JL, Wolff RA, et al., Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin: a single-institution experience. Cancer. 2010; 116: 316-322.
19. Farquharson AL, Pranesh N, Witham G, et al., A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei. Br J Cancer. 2008; 99: 591-596.
20. Lieu CH, Lambert LA, Wolff RA, et al., Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix. Ann Oncol. 2012; 23: 652-658.
21. Bradley RF, Stewart JH 4th, Russell GB, Levine EA, Geisinger KR,. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol. 2006; 30: 551-559.
22. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM,. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei." Am J Surg Pathol. 1995; 19: 1390-1408.